View in EDS

Neoantigen Targeting as a Novel Approach for Therapy-Resistant Tumors.

Saved in:
Bibliographic Details
Title: Neoantigen Targeting as a Novel Approach for Therapy-Resistant Tumors.
Authors: Okada M; Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan., Yamasaki S; Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan., Sato GR; Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan., Shimizu K; Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan., Fujii SI; Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan. shin-ichiro.fujii@riken.jp.; RIKEN Program for Drug Discovery and Medical Technology Platforms, RIKEN, Yokohama, Kanagawa, Japan. shin-ichiro.fujii@riken.jp.
Source: Molecular diagnosis & therapy [Mol Diagn Ther] 2026 May; Vol. 30 (3), pp. 495-514. Date of Electronic Publication: 2026 Mar 30.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101264260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2000 (Electronic) Linking ISSN: 11771062 NLM ISO Abbreviation: Mol Diagn Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41912995
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neoantigen Targeting as a Novel Approach for Therapy-Resistant Tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Okada+M%22">Okada M</searchLink>; Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan.<br /><searchLink fieldCode="AU" term="%22Yamasaki+S%22">Yamasaki S</searchLink>; Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan.<br /><searchLink fieldCode="AU" term="%22Sato+GR%22">Sato GR</searchLink>; Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan.<br /><searchLink fieldCode="AU" term="%22Shimizu+K%22">Shimizu K</searchLink>; Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan.<br /><searchLink fieldCode="AU" term="%22Fujii+SI%22">Fujii SI</searchLink>; Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences, 1-7-22, Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan. shin-ichiro.fujii@riken.jp.; RIKEN Program for Drug Discovery and Medical Technology Platforms, RIKEN, Yokohama, Kanagawa, Japan. shin-ichiro.fujii@riken.jp.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101264260%22">Molecular diagnosis & therapy</searchLink> [Mol Diagn Ther] 2026 May; Vol. 30 (3), pp. 495-514. <i>Date of Electronic Publication: </i>2026 Mar 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101264260 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-2000 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211771062%22">11771062 </searchLink><i>NLM ISO Abbreviation: </i>Mol Diagn Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41912995
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40291-026-00842-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 495
    Titles:
      – TitleFull: Neoantigen Targeting as a Novel Approach for Therapy-Resistant Tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Okada M
      – PersonEntity:
          Name:
            NameFull: Yamasaki S
      – PersonEntity:
          Name:
            NameFull: Sato GR
      – PersonEntity:
          Name:
            NameFull: Shimizu K
      – PersonEntity:
          Name:
            NameFull: Fujii SI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-2000
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Molecular diagnosis & therapy
              Type: main
ResultId 1